CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

10-Hydroxycamptothecin 100mg  | ≥98%

CSNpharm

10-Hydroxycamptothecin is an inhibitor of topoisomerase I and can affect phosphorylation of histone H1 and H3 with anticancer activity. It can be isolated from camptotheca acuminate.

More Information Supplier Page

10-Hydroxycamptothecin 25mg  | ≥98%

CSNpharm

10-Hydroxycamptothecin is an inhibitor of topoisomerase I and can affect phosphorylation of histone H1 and H3 with anticancer activity. It can be isolated from camptotheca acuminate.

More Information Supplier Page

10-Hydroxydecanoic acid 100mg  | ≥99%

CSNpharm

10-Hydroxydecanoic Acid is an occlusive skin conditioning agent: it creates a barrier on the skin that prevents water loss, thus helping to keep it hydrated.

More Information Supplier Page

1400W 2HCl 100mg  | ≥98%

CSNpharm

1400W 2HCl is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase (iNOS).

More Information Supplier Page

17-AAG 25mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

17-AAG 5mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

17-AAG 250mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

17-AAG 100mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

17-AAG 10mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

1NM-PP1(PP1 Analog II) 1mg  | ≥99%

CSNpharm

1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors with IC50 of 28 μM for vSrc and 4.2 nM for v-Src-as1 I338G.

More Information Supplier Page

1NM-PP1(PP1 Analog II) 50mg  | ≥99%

CSNpharm

1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors with IC50 of 28 μM for vSrc and 4.2 nM for v-Src-as1 I338G.

More Information Supplier Page

1NM-PP1(PP1 Analog II) 10mg  | ≥99%

CSNpharm

1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors with IC50 of 28 μM for vSrc and 4.2 nM for v-Src-as1 I338G.

More Information Supplier Page

1NM-PP1(PP1 Analog II) 5mg  | ≥99%

CSNpharm

1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors with IC50 of 28 μM for vSrc and 4.2 nM for v-Src-as1 I338G.

More Information Supplier Page

2-(3,4-Dihydroxyphenyl)ethanol 50mg  | ≥99%

CSNpharm

2-(3,4-Dihydroxyphenyl)ethanol is a potent and specific inhibitor of lipoxygenase activities, inhibits platelet 12-LO activity with IC50 of 4.2 mM and PMNL 5-LO activity with IC50 of 13 mM. It’s a natural product isolated and purified from the herbs of Canarium album with antioxidant property.

More Information Supplier Page

2-(3,4-Dihydroxyphenyl)ethanol 250mg  | ≥99%

CSNpharm

2-(3,4-Dihydroxyphenyl)ethanol is a potent and specific inhibitor of lipoxygenase activities, inhibits platelet 12-LO activity with IC50 of 4.2 mM and PMNL 5-LO activity with IC50 of 13 mM. It’s a natural product isolated and purified from the herbs of Canarium album with antioxidant property.

More Information Supplier Page

2-(3,4-Dihydroxyphenyl)ethanol 10mg  | ≥99%

CSNpharm

2-(3,4-Dihydroxyphenyl)ethanol is a potent and specific inhibitor of lipoxygenase activities, inhibits platelet 12-LO activity with IC50 of 4.2 mM and PMNL 5-LO activity with IC50 of 13 mM. It’s a natural product isolated and purified from the herbs of Canarium album with antioxidant property.

More Information Supplier Page

2-(4-Hydroxyphenyl)ethanol 25mg  | ≥99%

CSNpharm

2-(4-Hydroxyphenyl)ethanol is a natural product isolated and purified from the leaves of Canarium album, which significantly protects dopaminergic neurons from MPP(+)-induced degradation, and reveals potential neuroprotective mechanism of tyrosol.

More Information Supplier Page

2-(4-Hydroxyphenyl)ethanol 100mg  | ≥99%

CSNpharm

2-(4-Hydroxyphenyl)ethanol is a natural product isolated and purified from the leaves of Canarium album, which significantly protects dopaminergic neurons from MPP(+)-induced degradation, and reveals potential neuroprotective mechanism of tyrosol.

More Information Supplier Page

2-Amino-6-chloropurine 100mg  | ≥99%

CSNpharm

2-Amino-6-chloropurine is used in the enzymatic synthesis of 2′-deoxyguanosine. 6-Chloroguanine was found to be a substrate for P. falciparum HGXPRT (Hypoxanthine-guanine-xanthine phosphoribosyltransferase). It inhibited [3H]hypoxanthine uptake into parasites with IC50 of 67µM.

More Information Supplier Page